Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome

Hy Chin, K. C. Lin, C. H. Chiang, C. J. Wang

Research output: Contribution to journalArticle

Abstract

PURPOSE OF STUDY: The aim of this study was to evaluate the efficacy of uroflowmetry in predicting the possibility of abnormal voiding symptoms following antimuscarinic treatment for overactive bladder syndrome (OAB) in Taiwanese women.

MATERIALS AND METHODS: A retrospective study was conducted on women with OAB. Forty-five women with abnormal voiding patterns shown by urodynamic study comprised the main group and 38 women with normal voiding patterns comprised the control group. All patients were prescribed two mg tolterodine once daily for one week. Follow-up on complaints of abnormal voiding symptoms was done one week later.

RESULTS: One woman in control group and 12 women in main group complained of abnormal voiding symptoms. There was a significant difference in the occurrence of abnormal voiding symptoms after antimuscarinic administration between main study group and control group (26.7 % vs 2.6 %, p = 0.02). CONCLUSIOn: Uroflowmetry is a non-invasive and simple tool to predict the occurrence of abnormal voiding symptoms after antimuscarinic use.

Original languageEnglish
Pages (from-to)152-155
Number of pages4
JournalClinical and experimental obstetrics & gynecology
Volume42
Issue number2
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Overactive Urinary Bladder
Muscarinic Antagonists
Control Groups
Urodynamics
Retrospective Studies

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

@article{bed3ce8de22742e5aae021fa4dca928f,
title = "Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome",
abstract = "PURPOSE OF STUDY: The aim of this study was to evaluate the efficacy of uroflowmetry in predicting the possibility of abnormal voiding symptoms following antimuscarinic treatment for overactive bladder syndrome (OAB) in Taiwanese women.MATERIALS AND METHODS: A retrospective study was conducted on women with OAB. Forty-five women with abnormal voiding patterns shown by urodynamic study comprised the main group and 38 women with normal voiding patterns comprised the control group. All patients were prescribed two mg tolterodine once daily for one week. Follow-up on complaints of abnormal voiding symptoms was done one week later.RESULTS: One woman in control group and 12 women in main group complained of abnormal voiding symptoms. There was a significant difference in the occurrence of abnormal voiding symptoms after antimuscarinic administration between main study group and control group (26.7 {\%} vs 2.6 {\%}, p = 0.02). CONCLUSIOn: Uroflowmetry is a non-invasive and simple tool to predict the occurrence of abnormal voiding symptoms after antimuscarinic use.",
keywords = "Overactive bladder, Antimuscarinics, Urodynamics, Voiding pattern, Uroflowmetry",
author = "Hy Chin and Lin, {K. C.} and Chiang, {C. H.} and Wang, {C. J.}",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "42",
pages = "152--155",
journal = "Clinical and Experimental Obstetrics and Gynecology",
issn = "0390-6663",
publisher = "S.O.G. CANADA Inc.",
number = "2",

}

TY - JOUR

T1 - Single uroflow study as a tool in predicting the possibility of abnormal voiding symptoms after the administration of antimuscarinic agents in treating overactive bladder syndrome

AU - Chin, Hy

AU - Lin, K. C.

AU - Chiang, C. H.

AU - Wang, C. J.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - PURPOSE OF STUDY: The aim of this study was to evaluate the efficacy of uroflowmetry in predicting the possibility of abnormal voiding symptoms following antimuscarinic treatment for overactive bladder syndrome (OAB) in Taiwanese women.MATERIALS AND METHODS: A retrospective study was conducted on women with OAB. Forty-five women with abnormal voiding patterns shown by urodynamic study comprised the main group and 38 women with normal voiding patterns comprised the control group. All patients were prescribed two mg tolterodine once daily for one week. Follow-up on complaints of abnormal voiding symptoms was done one week later.RESULTS: One woman in control group and 12 women in main group complained of abnormal voiding symptoms. There was a significant difference in the occurrence of abnormal voiding symptoms after antimuscarinic administration between main study group and control group (26.7 % vs 2.6 %, p = 0.02). CONCLUSIOn: Uroflowmetry is a non-invasive and simple tool to predict the occurrence of abnormal voiding symptoms after antimuscarinic use.

AB - PURPOSE OF STUDY: The aim of this study was to evaluate the efficacy of uroflowmetry in predicting the possibility of abnormal voiding symptoms following antimuscarinic treatment for overactive bladder syndrome (OAB) in Taiwanese women.MATERIALS AND METHODS: A retrospective study was conducted on women with OAB. Forty-five women with abnormal voiding patterns shown by urodynamic study comprised the main group and 38 women with normal voiding patterns comprised the control group. All patients were prescribed two mg tolterodine once daily for one week. Follow-up on complaints of abnormal voiding symptoms was done one week later.RESULTS: One woman in control group and 12 women in main group complained of abnormal voiding symptoms. There was a significant difference in the occurrence of abnormal voiding symptoms after antimuscarinic administration between main study group and control group (26.7 % vs 2.6 %, p = 0.02). CONCLUSIOn: Uroflowmetry is a non-invasive and simple tool to predict the occurrence of abnormal voiding symptoms after antimuscarinic use.

KW - Overactive bladder

KW - Antimuscarinics

KW - Urodynamics

KW - Voiding pattern

KW - Uroflowmetry

UR - http://www.scopus.com/inward/record.url?scp=84938942646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938942646&partnerID=8YFLogxK

M3 - Article

VL - 42

SP - 152

EP - 155

JO - Clinical and Experimental Obstetrics and Gynecology

JF - Clinical and Experimental Obstetrics and Gynecology

SN - 0390-6663

IS - 2

ER -